Last reviewed · How we verify
NCT06273449
A Smart Digital Workflow Towards High Precision and Through-Put Production for Removable Partial Dentures
NA trial testing Group 3 - 3D Printed Removable Partial Denture in Partial-edentulism in 141 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | National Dental Centre, Singapore |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 141 |
| Start date | 29 December 2022 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Group 3 - 3D Printed Removable Partial Denture
- Group 2 - 3D Printed Removable Partial Denture
Conditions studied
- Partial-edentulism — all drugs for Partial-edentulism →
Sponsor
National Dental Centre, Singapore — full company profile →
Who can join
21 and older, any sex, with Partial-edentulism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Tooth loss is a major chronic problem in dentistry and edentulous elderly endures poorer quality of life worldwide. Removable partial dentures (RPDs) are the most widely accepted and cost-effective treatment for patients to restore oral functions. RPDs contain three components including the metal framework, denture base and acrylic teeth. Conventionally, RPD fabrication involves tedious clinical and dental laboratory procedures and is time consuming, labour-intensive, and often imprecise, therefore incapable of meeting the growing demands of RPD by an ageing population. The challenges to achieve a high quality and high-throughput RPD service lie in three aspects: 1) accuracy in capturing oral profile; 2) immediate oral information analysis and device design, and 3) automation in production.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06273449
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Partial-edentulism
Currently open trials in the same condition.
- NCT04927819 — Extra-short vs. Non-extra-short Dental Implants Splinted on the Same Prosthesis · recruiting
- NCT04378140 — Retention and Durability of the Anterior Zirconia Wing Bridge · active not recruiting
- NCT04695899 — Zirconia Implants for Replacement of a Single Tooth · active not recruiting
Other National Dental Centre, Singapore trials
Trials by the same sponsor.
- NCT06457321 — Implementation of Digital Workflow for Complete Dentures - A Crossover Study · NA · not yet recruiting
- NCT04304222 — Application of 3D Printed Removable Denture Prosthesis Framework for Partial Edentulous Patients · NA · completed
- NCT03735199 — 3D Printed Scaffold Device for Ridge Preservation After Tooth Extraction · NA · completed
- NCT03698851 — Assessment of the Accuracy of the Clinical Parameters & Radiographs in Determining the Topography of Implant Bony Lesion · NA · terminated
- NCT04036890 — Local Minocycline in Patients Under Supportive Periodontal Therapy · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06273449 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Dental Centre, Singapore
- Last refreshed: 9 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06273449.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing